chr17-81116271-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000321300.10(BAIAP2):c.1625G>A(p.Gly542Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,612,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000321300.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BAIAP2 | NM_001144888.2 | c.*432G>A | 3_prime_UTR_variant | 14/14 | ENST00000428708.7 | NP_001138360.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BAIAP2 | ENST00000428708.7 | c.*432G>A | 3_prime_UTR_variant | 14/14 | 1 | NM_001144888.2 | ENSP00000401022 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.0000360 AC: 9AN: 249950Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135554
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460536Hom.: 0 Cov.: 33 AF XY: 0.0000165 AC XY: 12AN XY: 726568
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152244Hom.: 0 Cov.: 35 AF XY: 0.0000269 AC XY: 2AN XY: 74388
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2023 | The c.1625G>A (p.G542E) alteration is located in exon 15 (coding exon 15) of the BAIAP2 gene. This alteration results from a G to A substitution at nucleotide position 1625, causing the glycine (G) at amino acid position 542 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at